Company news
Kissei Pharmaceutical Co., Ltd. news in 2024
Kissei Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2024, newest first.
Notice Concerning the Results of the Acquisition of Treasury Shares, Through Off Auction Treasury Share Repurchase Trading System (ToSTNeT 3), the Completion of Acquisition of Treasury shares and the Cancellation of Treasury Shares
November 5, 2024
Notice on the Acquisition of Treasury Shares, the Acquisition of Treasury Shares Through Off Auction Own Share Repurchase Trading System (ToSTNeT 3) and the Cancellation of Treasury Shares
November 5, 2024
Succession of Manufacturing and Marketing Authorization for MARIZEV®, Diabetes Treatment
September 24, 2024
Launch of YSELTY® (generic name linzagolix) for uterine fibroid treatment in Europe
September 16, 2024
Notice Concerning Status of Acquisition and Completion of the Company's Own Shares
March 19, 2024
Notice Concerning Status of Acquisition of the Company's Own Shares
March 1, 2024